date,title,source
Oct-29-18,Filing under Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Precision Therapeutics Inc.: SEC File Nos. 001-36790; and 333-221966,GlobeNewswire
Nov-05-18,Precision Therapeutics CEO Talks with Uptick Newswires Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and Whats on the Horizon,GlobeNewswire
Nov-07-18,Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation,GlobeNewswire
